Xiao Lu

Xiao Lu

Auto-generated profile, based on publicly available information

Xiao Lu

Department of Orthopedics, Huashan Hospital, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2023 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
GXGuangyu Xu
Guangyu Xu
XLXiao Lu
Xiao Lu
SLSiyang Liu
Siyang Liu
YZYuxuan Zhang
Yuxuan Zhang
SXShun Xu
Shun Xu
JJJianyuan Jiang
Jianyuan Jiang

7 January 2023 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
XLXiao Lu
Xiao Lu
GXGuangyu Xu
Guangyu Xu
ZLZhidi Lin
Zhidi Lin
JSJian Song
Jian Song
YZYuxuan Zhang
Yuxuan Zhang
JJJianyuan Jiang
Jianyuan Jiang
Intervertebral disc degeneration (IVDD) is one of the main causes of low back pain, which brings heavy burdens to individuals and society. The mechanism of IVDD is complex and diverse. One of the important reasons is that the abnormal accumulation of reactive oxygen species (ROS) in nucleus pulposus cells (NPCs) leads to endoplasmic reticulum stress (ERS), which causes increased apoptosis of NPCs. Nuclear factor E2-related factor 2 (Nrf-2) and its downstream antioxidant proteins are key molecular switches for sensing oxidative stress and regulating antioxidant responses in cells. Sulforaphane (SFN), a natural compound derived from Brassicaceae plants, is a Nrf-2 agonist that displays potent antioxidant potential in vitro and in vivo. Here, we used advanced glycation end products (AGEs) to construct an in vitro degeneration model of NPCs, and we found that AGEs elevated ROS level in NPCs and caused severe ERS and apoptosis. While SFN can promote the entry of Nrf-2 into the nucleus and increase the expression level of heme oxygenase 1 (HO-1) in vitro, thus clearing the accumulated ROS in cells and alleviating ERS and cell apoptosis. Moreover, the protection of SFN on NPCs was greatly attenuated after HO-1 was inhibited. We also used AGEs to construct a rat IVDD model. Consistent with the in vitro experiments, SFN could attenuate ERS in NPCs in vivo and delay disc degeneration in rats. This study found that SFN can be used as a new and promising agent for the treatment of IVDD.